Cargando…
Single‐Cell RNA Sequencing for Precision Oncology: Current State-of-Art
Tumors exhibit genetic and phenotypic diversity leading to intra-tumor heterogeneity (ITH). Further complex ecosystem (stromal and immune cells) of tumors contributes into the ITH. This ITH allows tumors to overcome various selection pressures such as anti-cancer therapies and metastasis at distant...
Autores principales: | Seow, Justine Jia Wen, Wong, Regina Men Men, Pai, Rhea, Sharma, Ankur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264973/ https://www.ncbi.nlm.nih.gov/pubmed/32837038 http://dx.doi.org/10.1007/s41745-020-00178-1 |
Ejemplares similares
-
Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives
por: Subbiah, Vivek, et al.
Publicado: (2017) -
Computational single cell oncology: state of the art
por: Paas-Oliveros, Ernesto, et al.
Publicado: (2023) -
Dental-Derived Mesenchymal Stem Cells: State of the Art
por: Li, Bo, et al.
Publicado: (2021) -
Organoids as an Enabler of Precision Immuno-Oncology
por: Zhao, Junzhe, et al.
Publicado: (2023) -
Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2(+) Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
por: Seow, Justine Jia Wen, et al.
Publicado: (2021)